177 related articles for article (PubMed ID: 34900723)
1. LncRNA CASC11 Promotes Hepatocellular Carcinoma Progression
Chen F; Li M; Wang L
Front Oncol; 2021; 11():772671. PubMed ID: 34900723
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of long non-coding RNA cancer susceptibility 11 is involved in the development of chemoresistance to carboplatin in hepatocellular carcinoma.
Liu H; Liu T; Zhou Y; Song X; Wei R
Oncol Lett; 2020 Mar; 19(3):1993-1998. PubMed ID: 32194694
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of ubiquitin-conjugating enzyme E2T (UBE2T) predicts poor prognosis and promotes hepatocellular carcinoma progression.
Ren X; Li A; Ying E; Fang J; Li M; Yu J
Bioengineered; 2021 Dec; 12(1):1530-1542. PubMed ID: 33934686
[TBL] [Abstract][Full Text] [Related]
4. UBE2T promotes proliferation via G2/M checkpoint in hepatocellular carcinoma.
Liu LL; Zhu JM; Yu XN; Zhu HR; Shi X; Bilegsaikhan E; Guo HY; Wu J; Shen XZ
Cancer Manag Res; 2019; 11():8359-8370. PubMed ID: 31571992
[TBL] [Abstract][Full Text] [Related]
5. UBE2T-regulated H2AX monoubiquitination induces hepatocellular carcinoma radioresistance by facilitating CHK1 activation.
Sun J; Zhu Z; Li W; Shen M; Cao C; Sun Q; Guo Z; Liu L; Wu D
J Exp Clin Cancer Res; 2020 Oct; 39(1):222. PubMed ID: 33087136
[TBL] [Abstract][Full Text] [Related]
6. Ubiquitin-conjugating enzyme E2T knockdown suppresses hepatocellular tumorigenesis
Guo J; Wang M; Wang JP; Wu CX
World J Gastroenterol; 2019 Nov; 25(43):6386-6403. PubMed ID: 31798276
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA CASC11 suppresses sorafenib-triggered ferroptosis via stabilizing SLC7A11 mRNA in hepatocellular carcinoma cells.
Chen F; Wang L
Discov Oncol; 2023 Aug; 14(1):145. PubMed ID: 37552314
[TBL] [Abstract][Full Text] [Related]
8. STAT3-induced upregulation of lncRNA CASC11 promotes the cell migration, invasion and epithelial-mesenchymal transition in hepatocellular carcinoma by epigenetically silencing PTEN and activating PI3K/AKT signaling pathway.
Han Y; Chen M; Wang A; Fan X
Biochem Biophys Res Commun; 2019 Jan; 508(2):472-479. PubMed ID: 30503497
[TBL] [Abstract][Full Text] [Related]
9. UBE2T-mediated Akt ubiquitination and Akt/β-catenin activation promotes hepatocellular carcinoma development by increasing pyrimidine metabolism.
Zhu Z; Cao C; Zhang D; Zhang Z; Liu L; Wu D; Sun J
Cell Death Dis; 2022 Feb; 13(2):154. PubMed ID: 35169125
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA CASC11 promotes hepatocarcinogenesis and HCC progression through EIF4A3-mediated E2F1 activation.
Song H; Liu Y; Li X; Chen S; Xie R; Chen D; Gao H; Wang G; Cai B; Yang X
Clin Transl Med; 2020 Nov; 10(7):e220. PubMed ID: 33252856
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA CASC11 promotes osteosarcoma metastasis by suppressing degradation of snail mRNA.
Song K; Yuan X; Li G; Ma M; Sun J
Am J Cancer Res; 2019; 9(2):300-311. PubMed ID: 30906630
[TBL] [Abstract][Full Text] [Related]
12. In Vivo Genome-Wide CRISPR Activation Screening Identifies Functionally Important Long Noncoding RNAs in Hepatocellular Carcinoma.
Wong LS; Wei L; Wang G; Law CT; Tsang FH; Chin WC; Ng IO; Wong CM
Cell Mol Gastroenterol Hepatol; 2022; 14(5):1053-1076. PubMed ID: 35944892
[TBL] [Abstract][Full Text] [Related]
13. UBE2T promotes hepatocellular carcinoma cell growth via ubiquitination of p53.
Liu LP; Yang M; Peng QZ; Li MY; Zhang YS; Guo YH; Chen Y; Bao SY
Biochem Biophys Res Commun; 2017 Nov; 493(1):20-27. PubMed ID: 28935368
[TBL] [Abstract][Full Text] [Related]
14. LncRNA CASC11 promotes cancer cell proliferation in hepatocellular carcinoma by inhibiting miRNA-188-5p.
Cheng N; Wu J; Yin M; Xu J; Wang Y; Chen X; Nie Z; Yin J
Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30910841
[TBL] [Abstract][Full Text] [Related]
15. LncRNA CASC11 promotes the cervical cancer progression by activating Wnt/beta-catenin signaling pathway.
Hsu W; Liu L; Chen X; Zhang Y; Zhu W
Biol Res; 2019 Jun; 52(1):33. PubMed ID: 31255182
[TBL] [Abstract][Full Text] [Related]
16. A crucial role for the long non-coding RNA
Zheng L; Guan Z; Xue M
Am J Transl Res; 2021; 13(9):10922-10932. PubMed ID: 34650773
[TBL] [Abstract][Full Text] [Related]
17. Ubiquitin-conjugating enzyme E2T(UBE2T) promotes colorectal cancer progression by facilitating ubiquitination and degradation of p53.
Wu M; Li X; Huang W; Chen Y; Wang B; Liu X
Clin Res Hepatol Gastroenterol; 2021 Mar; 45(2):101493. PubMed ID: 32736946
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA CASC11 interacts with hnRNP-K and activates the WNT/β-catenin pathway to promote growth and metastasis in colorectal cancer.
Zhang Z; Zhou C; Chang Y; Zhang Z; Hu Y; Zhang F; Lu Y; Zheng L; Zhang W; Li X; Li X
Cancer Lett; 2016 Jun; 376(1):62-73. PubMed ID: 27012187
[TBL] [Abstract][Full Text] [Related]
19. LncRNA CASC11 promotes the development of esophageal carcinoma by regulating KLF6.
Chen SG; Wang CH; He RQ; Xu RY; Ji CB
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8878-8887. PubMed ID: 31696474
[TBL] [Abstract][Full Text] [Related]
20. Ubiquitin-conjugating enzyme E2T promotes tumor stem cell characteristics and migration of cervical cancer cells by regulating the GRP78/FAK pathway.
Liu Y; Ji W; Yue N; Zhou W
Open Life Sci; 2021; 16(1):1082-1090. PubMed ID: 34703898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
